Related Experiment Video

Updated: Aug 8, 2026

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
06:38

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Published on: November 8, 2011

Oligoclonal B-cell leukemia characterized by spontaneous cell division and telomere association

P E Crossen1, S M Tully, S M Benjes

  • 1Cytogenetic and Molecular Oncology Unit, Christchurch Hospital, New Zealand.

Genes, Chromosomes & Cancer
|September 1, 1993
PubMed

Insights

This study reveals chronic B-cell leukemia (CLL) can be oligoclonal, meaning multiple leukemia cell populations exist. This finding, supported by genetic analysis, offers new insights into leukemia complexity.

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Chronic B-cell leukemia (CLL) is typically considered a monoclonal malignancy.
  • Understanding the clonal architecture of CLL is crucial for prognosis and treatment.

Observation:

  • Cytogenetic analysis of a female patient's unstimulated CLL cultures identified three distinct cytogenetic clones.
  • Immunoglobulin heavy chain gene rearrangement studies showed one germline and four rearranged bands.
  • X-linked restriction fragment length polymorphism (RFLP) studies further supported an oligoclonal leukemic population.

Findings:

  • This is the first report demonstrating oligoclonality in CLL using cytogenetic, immunoglobulin gene rearrangement, and X-chromosome inactivation studies.
  • The patient's leukemic cells also exhibited telomere association, a Robertsonian translocation, and clonal evolution.
  • These findings suggest an underlying genomic instability in the patient's CLL.

Implications:

  • The study challenges the traditional view of CLL as solely monoclonal.
  • Oligoclonality in CLL may have significant implications for disease progression and therapeutic strategies.
  • Identifying genomic instability alongside oligoclonality provides a more comprehensive understanding of CLL pathogenesis.

More Related Videos

Chromosome Preparation From Cultured Cells07:42

Chromosome Preparation From Cultured Cells

Published on: January 28, 2014

Generation of Cancer Cell Clones to Visualize Telomeric Repeat-containing RNA TERRA Expressed from a Single Telomere in Living Cells09:13

Generation of Cancer Cell Clones to Visualize Telomeric Repeat-containing RNA TERRA Expressed from a Single Telomere in Living Cells

Published on: January 17, 2019

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...